Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.8%

18 terminated/withdrawn out of 232 trials

Success Rate

90.3%

+3.8% vs industry average

Late-Stage Pipeline

9%

21 trials in Phase 3/4

Results Transparency

49%

82 of 168 completed trials have results

Key Signals

15 recruiting82 with results13 terminated5 withdrawn

Enrollment Performance

Analytics

N/A
65(33.5%)
Phase 2
65(33.5%)
Phase 1
37(19.1%)
Phase 3
17(8.8%)
Early Phase 1
6(3.1%)
Phase 4
4(2.1%)
194Total
N/A(65)
Phase 2(65)
Phase 1(37)
Phase 3(17)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (232)

Showing 20 of 232 trials
NCT06160934Not ApplicableActive Not Recruiting

The T1D Parent Check-In: A Preventative Intervention

Role: collaborator

NCT05145491Not ApplicableRecruiting

Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

Role: collaborator

NCT05949281Phase 2Active Not Recruiting

Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes

Role: collaborator

NCT05904028Phase 3Active Not Recruiting

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Role: collaborator

NCT06308549Not ApplicableCompleted

MyDiaMate For Remission Of Diabetes Distress In Type 1 Diabetes (MyREMEDY)

Role: collaborator

NCT05463289Not ApplicableRecruiting

ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2

Role: collaborator

NCT03655223Active Not Recruiting

Early Check: Expanded Screening in Newborns

Role: collaborator

NCT04661358Phase 3Active Not Recruiting

Fenofibrate for Prevention of DR Worsening

Role: collaborator

NCT06172166Not ApplicableRecruiting

Transdisciplinary Care for Young Adults With Type 1 Diabetes

Role: collaborator

NCT05594563Phase 2Active Not Recruiting

TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

Role: collaborator

NCT05000021Not ApplicableActive Not Recruiting

Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes

Role: collaborator

NCT05822609Phase 2Recruiting

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Role: collaborator

NCT06296992Not ApplicableRecruiting

Type 1 Diabetes, Exercise and Mentoring Trial

Role: collaborator

NCT06709755Not ApplicableRecruiting

A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers

Role: collaborator

NCT03899402Phase 2Active Not Recruiting

Triple Therapy in T1DM

Role: collaborator

NCT04545151Phase 2Completed

Verapamil SR in Adults With Type 1 Diabetes

Role: collaborator

NCT03961854Phase 2Completed

Lactobacillus Johnsonii in Children and Adolescents With T1D

Role: collaborator

NCT06300047Not ApplicableEnrolling By Invitation

Diabetes Transition Coordinator Study

Role: collaborator

NCT05899439Recruiting

Immune Function and the Progression to T1D

Role: collaborator

NCT03999853Phase 1Completed

Butyrate Adjuvant Therapy for Type 1 Diabetes

Role: collaborator